| Product Information |
| Synonym(s) |
LY 2157299, LY-2157299, Galunisertib |
| Chemical Name |
4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide |
| Application |
LY2157299 is a potent TGF ¦Â RI inhibitor |
| CAS Number |
700874-72-2 |
| Purity |
¡Ý98.0% |
| Molecular Weight |
369.42 |
| Molecular Formula |
C₂₂H₁₉N₅O |
| SMILES |
CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N |
| Target & IC50 |
Flk-1: IC50 = 442 nM TGF¦Â RI: IC50 = 56 nM |
| Solubility |
DMSO: 74 mg/mL (200.31 mM) |
| Preparing Stock Solutions |
| ConcentrationSolventMass |
1 mg |
5 mg |
10 mg |
| 1 mM |
2.7069 ml |
13.5347 ml |
27.0695 ml |
| 5 mM |
0.5414 ml |
2.7069 ml |
5.4139 ml |
| 10 mM |
0.2707 ml |
1.3535 ml |
2.7070 ml |
| 50 mM |
0.0541 ml |
0.2707 ml |
0.5414 ml |
|
| Shipping |
Gel Pack |
| Storage |
Store at -20¡ãC |
| Research Use |
For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |